$GWPH Announces Second Positive Phase 3 Pivotal Trial for Epidiolex®

GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol)…

$MCIG Announces 1st Quarter ’17 Financials

mCig, Inc., Announces First Quarter 2017 Financial Results (Unaudited) HENDERSON, NV–(Marketwired –…

Scientist Have Now Gained Easier Access To Cannabis for Research Purposes

The DEA recently eliminated one obstacle for medical marijuana researchers. It announced…

FDA Study Indicates Inconsistencies in Labeling of Cannabidiol Products Sold

With the recent sanctioning of cannabis items for either therapeutic or recreational…